Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 524 of 710

Advanced search

🌍Jul 15discoverynews.google.comTier 2 · Trade media

Judge orders Apple Tree partner to forfeit oversight of venture fund

BioPharma DiveOriginal source

🌍Jul 15Medialemsurgical.comTier 2 · Direct publisher

Data is the New Commodity, While the Surgical Robot is the True Enabler of the New Economy

LEM Surgical (Dynamis Spine Robot)Original source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

The unapproved but very online weight-loss drug

PoliticoOriginal source

🌍Jul 15discoverynews.google.comTier 3 · Aggregated media

FDA outlines process for for oil safety after recall

Taipei TimesOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

The Product That’s Helping My Blowout Survive a New York Summer

AllureOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio

MorningstarOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

FDA finalises psychedelic clinical trial guidance

YahooOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Ministerial Group for Digital Inclusion: terms of reference

Terms of reference for Ministerial Group for Digital Inclusion.

UK Department of Health and Social CareOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Ministerial Group for Digital Inclusion: meeting summaries

Summary of minutes of the meetings for the Ministerial Group for Digital Inclusion.

UK Department of Health and Social CareOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

CNBCOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

South Korea's Bio-Pharmaceutical Exports Reach Record $4.5 Billion

조선일보Original source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

New biotech Avere plots listing via NextCure merger

pharmaphorumOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical Discloses Transactions With Avere Therapeutics

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech news from around the world

NatureOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Waste Outreach Program

OCFL NewsroomOriginal source

🇺🇸Jul 14Regulatoryfda.govTier 1 · Regulatory source

Notifications on Data Integrity

FDA Drug Safety CommunicationsOriginal source

🇺🇸Jul 14Industry4gclinical.comTier 1 · Company source

The Operational Cost of “We’ll Add That Later”

4G ClinicalOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

DHSC equality information

DHSC equality objectives and information relating to our public sector equality duties.

UK Department of Health and Social CareOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

DHSC equality information: 2025

A report setting out how the Department of Health and Social Care (DHSC) has responded to its equali...

UK Department of Health and Social CareOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Dr. S. Leigh Verbois Named Chief Executive Officer of Rx-360

MorningstarOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

US Sunscreens Just Got More Effective. BU Dermatologist Explains Why

Boston UniversityOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Cannara Biotech Lands A First Long-Term Export Supply Deal

FinimizeOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech companies tout benefits of AI-assisted drug development

BioXconomyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

After K Rustom, FDA suspends licences of Mumbai’s iconic Shalimar, Noor Mohammadi over alleged hygiene lapses

The Indian ExpressOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Akero team, backed by Fairmount, launches new immunology company

STATOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Ionis stock rating on trial dosing

Investing.com UKOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'

Fierce PharmaOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics

Pharmaceutical ExecutiveOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Russian billionaire wins fight to boot manager of biotech fund

Crain CurrencyOriginal source

🇺🇰Jul 14Researchsphr.nihr.ac.ukTier 2 · Direct publisher

NIHR SPHR fellowships in public health research 2026

NIHR School for Public Health ResearchOriginal source

🇯🇵Jul 14CROen.cmicgroup.comTier 2 · Direct publisher

OCT Southeast 2027

CMIC Group JapanOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech Visionary John F. Crowley to Keynote Emily Whitehead Foundation's 2026 Believe Ball in Philadelphia

PR NewswireOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biogen plans phase 3 trial for Alzheimer’s drug diranersen

Investing.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biotech funding gap widens despite rebound in VC investment

Pharma VoiceOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biogen plans phase 3 trial for Alzheimer’s drug diranersen By Investing.com

Investing.com IndiaOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

IPOs juice biotech real estate (if only a little), but vacancy still climbs and lease rates tumble

The Business JournalsOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Biogen plans phase 3 trial for Alzheimer’s drug diranersen By Investing.com

Investing.com CanadaOriginal source

🇺🇰Jul 14Regulatorygov.ukTier 1 · Regulatory source

Tuberculosis in England national quarterly report: Q2 2026

The latest report presenting provisional quarterly data on tuberculosis (TB) case notifications and...

UK Health Security AgencyOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical manufacturing: Validation, batch integrity, and what a cyber incident actually costs

Industrial CyberOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Shortly after bankruptcy: IO Biotech founder takes on new top position

medwatch.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Germany passes bill despite criticism from pharmaceutical companies

medwatch.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Novel vaccine framework illustrates promise for oral cancer vaccines

European Pharmaceutical ReviewOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Summit sells failed antibiotic to OpenAI-backed startup in $105M deal

Fierce BiotechOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs

BioPharma DiveOriginal source

🇪🇺Jul 14Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Antibiotic Resistance: Socio-Economic Determinants and the Role of Information and Salience in Treatment Choice

CORDISOriginal source

🇪🇺Jul 14Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Comprehensive Platform for the Functional Characterization of Cancer Epigenetics and Diagnosis

CORDISOriginal source

🇪🇺Jul 14Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: EBRAINS 2.0: A Research Infrastructure to Advance Neuroscience and Brain Health

CORDISOriginal source

🇪🇺Jul 14Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Development and evaluation of Radical Oxygen Species (ROS)-responsive drug delivery systems to prevent and cure inflammatory and hypoxic diseases.

CORDISOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows

STATOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Sound Pharma completes enrollment of Open Label Phase 3 study of SPI-1005 in Meniere’s Disease

Yahoo Finance SingaporeOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Danish biotech sells future royalties to bring its first product to market

medwatch.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China

markets.businessinsider.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That

TradingViewOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

markets.businessinsider.comOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

AI/ML in Practice: Machine-learning Prediction of Chromatographic Retention Times for Small Molecules in Pharmaceutical Applications

Chromatography OnlineOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

Compass Has Two Positive Phase 3 Trials. The FDA Has Final Guidance. So Why Does Psilocybin Still Feel Like a Gamble?

The Clinical Trial VanguardOriginal source

🌍Jul 14discoverynews.google.comTier 2 · Trade media

Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.

BioSpaceOriginal source

🌍Jul 14Researchindicalab.comTier 2 · Direct publisher

HALO AP 2.5: Scaling Digital Pathology with Intelligent Workflow Orchestration

Indica LabsOriginal source

🌍Jul 14Researchindicalab.comTier 2 · Direct publisher

HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability

Indica LabsOriginal source

🌍Jul 14discoverynews.google.comTier 3 · Aggregated media

FDA Issues Proposal to Streamline Registration for Advanced Distributed Manufacturers

Genetic Engineering and Biotechnology NewsOriginal source